Pfizer-BioNTech Omicron retooled booster authorised in Canada Ruchika Sharma8 Oct 2022 1:17 PM ISTRegulators in the European Union and Japan have also cleared Pfizer's updated booster shot.
Pfizer, BioNTech complete submission to EMA for Omicron BA.4/BA.5-Adapted Bivalent vaccine booster in children aged 5 Through 11 years Ruchika Sharma2 Oct 2022 3:45 PM ISTCOMIRNATY, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster for Children aged 5 through 11 years Ruchika Sharma27 Sept 2022 11:15 AM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
CEO of Pfizer tests COVID positive again Ruchika Sharma26 Sept 2022 1:45 PM ISTThe chief executive said he has not yet taken the new bivalent booster.
Pfizer COVID vaccine approved for children as young as six months in Brazil Ruchika Sharma19 Sept 2022 1:30 PM ISTRio De Janeiro: Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between...
Pfizer- BioNTech get positive CHMP opinion for conversion of COMIRNATY conditional marketing nod to full marketing nod in EU Ruchika Sharma18 Sept 2022 9:00 AM ISTNew Delhi: Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Pfizer, BioNTech Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster get CHMP nod Ruchika Sharma14 Sept 2022 11:37 AM ISTIf an authorization is granted, the Pfizer-BioNTech bivalent Omicron BA.4/BA.5 COVID-19 vaccine will be available within the coming days to all 27 EU...
Pfizer-BioNTech bivalent booster for Omicron, original COVID strain gets UK nod Ruchika Sharma5 Sept 2022 12:45 PM ISTIn each dose of the booster vaccine called "Comirnaty bivalent Original/Omicron", half of the vaccine (15 micrograms) targets the original virus...
Pfizer, BioNTech seek to revoke CureVac patent infringement claims Ruchika Sharma4 Sept 2022 4:51 PM ISTNew Delhi: Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their...
Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and older Ruchika Sharma2 Sept 2022 2:00 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
COVID: BioNTech to supply new vaccine very soon to neutralise Omicron MD Bureau28 Aug 2022 4:55 PM ISTThe new vaccine is, however, still expected to be more effective in neutralising the variants currently in circulation, the report said.
Alleging patent infringement, Moderna sues Pfizer-BioNtech over use of mRNA technology in COVID vaccine Ruchika Sharma27 Aug 2022 5:00 PM ISTPfizer said the company was confident in its intellectual property and would vigorously defend against the allegations.
